Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

September-October 2004; Volume 24,Issue 5C

Proceedings of the Joint Meeting of the 7th Annual Meeting of the Society of Biotherapeutic Approaches and the 2nd Annual Meeting of the Japan Research Association for Immunotherapeutics

  • You have access
    Preface
    Masamichi Tomonaga
    Anticancer Research September 2004, 24 (5C) 3289;
  • You have access
    Relationships Between Local and Systemic Expression of Interleukin-12 and Plasma Levels of Vascular Endothelial Growth Factor in Patients with Gastric Cancer
    YOSHIFUMI NAKAYAMA, YUZURU INOUE, NOBUO NAGASHIMA, TAKEFUMI KATSUKI, KENTAROU MATSUMOTO, KAZUNORI SHIBAO, KEISUKE TSURUDOME, KEIJI HIRATA, TATSUHIKO SAKO, NAOKI NAGATA and HIDEAKI ITOH
    Anticancer Research September 2004, 24 (5C) 3289-3294;
  • You have access
    Biological Effect of OK-432 (Picibanil) and Possible Application to Dendritic Cell Therapy
    YOSHIKI RYOMA, YOICHIRO MORIYA, MASATO OKAMOTO, ISAO KANAYA, MOTOO SAITO and MITSUNOBU SATO
    Anticancer Research September 2004, 24 (5C) 3295-3302;
  • You have access
    A Report of Three Patients Treated with Immunocell Therapy with Imatinib Mesylate
    TORU KANEKO, SHIGENORI GOTO, YOSHIAKI KUSHIMA, YOJU MIYAMOTO, MASAZUMI ERIGUCHI, MIE NIEDA and KOJI EGAWA
    Anticancer Research September 2004, 24 (5C) 3303-3310;
  • You have access
    Utilization of Macrophages in Anticancer Therapy: The Macrophage Network Theory
    CHIE KOHCHI, HIROYUKI INAGAWA, MAMI HINO, MUTSUMI ODA, KAZUE NAKATA, AYA YOSHIDA, HITOSHI HORI, HIROSHI TERADA, KIMIKO MAKINO, KUNIO TAKIGUCHI and GEN-ICHIRO SOMA
    Anticancer Research September 2004, 24 (5C) 3311-3320;
  • You have access
    Immuno-cell Therapy of Cancer in Japan
    KOHJI EGAWA
    Anticancer Research September 2004, 24 (5C) 3321-3326;
  • You have access
    Mature Dendritic Cells are Superior to Immature Dendritic Cells in Expanding Antigen-specific Naïve and Memory CD8+ T Cells
    MAI TOMIYAMA, MASASHI TAKAHARA, KOHJI EGAWA and MIE NIEDA
    Anticancer Research September 2004, 24 (5C) 3327-3334;
  • You have access
    Correlation of Histological Localization of Tumor-associated Macrophages with Clinicopathological Features in Endometrial Cancer
    SATOSHI OHNO, YUMIKO OHNO, NOBUTAKA SUZUKI, TSUTOMU KAMEI, KOJI KOIKE, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA and MASAKI INOUE
    Anticancer Research September 2004, 24 (5C) 3335-3342;
  • You have access
    Structural Analysis of Human Specific Cytolysin Intermedilysin Aiming Application to Cancer Immunotherapy
    KAZUTO OHKURA, HIDEAKI NAGAMUNE and HIROKI KOURAI
    Anticancer Research September 2004, 24 (5C) 3343-3354;
  • You have access
    Cloning and Sequencing of Variable Region cDNAs of a Novel Human Monoclonal Antibody to Carcinoembryonic Antigen, and Generation of a Single Chain Variable Fragmented Antibody
    HIROTOMO SHIBAGUCHI, MASAHIDE KUROKI, MOTOMU KUROKI, ADEL BADRAN, KEN HACHIMINE and TETSUSHI KINUGASA
    Anticancer Research September 2004, 24 (5C) 3355-3360;
  • You have access
    Association of the Macrophage Activating Factor (MAF) Precursor Activity with Polymorphism in Vitamin D-binding Protein
    HIDEKO NAGASAWA, HIDEYUKI SASAKI, YOSHIHIRO UTO, SHINICHI KUBO and HITOSHI HORI
    Anticancer Research September 2004, 24 (5C) 3361-3366;
  • You have access
    A Cell Membrane Modification Technique Using Domain 4 of Intermedilysin for Immunotherapy Against Cancer
    HIDEAKI NAGAMUNE, KAZUTO OHKURA, KAZUNORI UMETSU, HIDEKATSU SHOUJI and HIROKI KOURAI
    Anticancer Research September 2004, 24 (5C) 3367-3372;
  • You have access
    Tumor-targeting of Viral Vectors for Cancer Gene Therapy by Using Antibodies or their Genes against Tumor-associated Antigens
    MASAHIDE KUROKI, MOTOMU KUROKI, HIROTOMO SHIBAGUCHI, KEN HACHIMINE, TETSUSHI KINUGASA and ADEL BADRAN
    Anticancer Research September 2004, 24 (5C) 3373-3378;
  • You have access
    Tumor Cell-specific Transcription of a Murine Histocompatibility Class Ib Q5 Gene
    KATSUO NOGUCHI, ERI KUWADA, SHIGENORI GOTO and KOHJI EGAWA
    Anticancer Research September 2004, 24 (5C) 3379-3386;
  • You have access
    Detection of Anti-HLA-F Antibodies in Sera from Cancer Patients
    KATSUO NOGUCHI, MANAMI ISOGAI, ERI KUWADA, ATSUTAKA NOGUCHI, SHIGENORI GOTO and KOHJI EGAWA
    Anticancer Research September 2004, 24 (5C) 3387-3392;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 24, Issue 5C
September-October 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire